Table of Contents

• What is Aconite Pain Oil?
• Intended Use
• Clinical Trial Overview
• Potential Benefits
• Eligibility Criteria
• Safety and Side Effects
• Administration

What is Aconite Pain Oil?

Aconite Pain Oil, also known as “Aconit Schmerzöl” in German, is a medicinal product containing several active ingredients^[1]. The main components of this oil are:

• Aconitum napellus (a plant-based extract)
• D-Camphor (a natural compound found in some plants)
• Lavender oil (an essential oil known for its calming properties)
• Quartz (a mineral, used in a highly diluted form)

This oil is classified as an anthroposophic medicine, which is a type of complementary medicine that combines conventional medical treatments with a holistic approach to healing^[1].

Intended Use

Aconite Pain Oil is being studied for its potential to prevent and treat chemotherapy-induced polyneuropathy (CIPN)^[1]. CIPN is a common side effect of certain chemotherapy drugs, particularly taxanes and platinum derivatives. It causes nerve damage that can lead to pain, numbness, and tingling in the hands and feet.

Clinical Trial Overview

A clinical trial is currently underway to evaluate the effectiveness of Aconite Pain Oil in preventing and reducing symptoms of CIPN in cancer patients undergoing chemotherapy^[1]. The main objectives of this trial are:

1. To reduce the risk of developing grade II or higher CIPN by 35% compared to a placebo
2. To decrease CIPN symptoms in patients who develop them during treatment
3. To improve the quality of life for patients undergoing chemotherapy
4. To enhance sleep quality in patients
5. To reduce anxiety and depression associated with CIPN

Potential Benefits

If successful, Aconite Pain Oil could offer several benefits to cancer patients undergoing chemotherapy^[1]:

• Prevention or reduction of CIPN symptoms
• Improved quality of life during and after chemotherapy
• Better sleep quality
• Reduced anxiety and depression
• Potentially fewer chemotherapy dose reductions or discontinuations due to CIPN

Eligibility Criteria

The clinical trial has specific criteria for patient participation^[1]. Some key inclusion criteria are:

• Adults aged 18 or older
• Patients with solid tumors
• Scheduled to receive chemotherapy with taxanes or platinum derivatives for at least 3 months
• A Karnofsky Index (a measure of a patient’s general well-being) of 70% or higher

Exclusion criteria include certain pre-existing conditions, use of specific medications, and other factors that could interfere with the study results.

Safety and Side Effects

The clinical trial is designed to assess the safety and tolerability of Aconite Pain Oil^[1]. Patients with known hypersensitivity to any of the ingredients, including peanut or soy, are excluded from the trial. As with any medical treatment, it’s crucial to discuss potential risks and benefits with a healthcare provider.

Administration

Aconite Pain Oil is designed for external use and is applied to the skin^[1]. The maximum daily dose in the trial is 12 ml, and the treatment period can last up to 7 months. A special dosing cup is provided to measure the correct amount of oil for application.